Key Takeaways
- Frank Slootman, a director at Snowflake, offloaded 348,020 shares during August 18-19, 2026, generating $97.4 million in proceeds.
- The transactions occurred at prices ranging from $319.07 to $333.37 per share, executed through a Rule 10b5-1 trading arrangement.
- His direct ownership plummeted nearly 90%, with only 28,535 shares remaining in his direct portfolio.
- Shares of SNOW currently hover around $321, reflecting a 65% gain year-over-year and approaching the 52-week peak of $341.95.
- Wall Street sentiment stays positive: 34 analysts rate it a Buy, 5 suggest Hold, and 1 recommends Sell, with an average target of $320.65.
A major insider transaction at Snowflake (SNOW) caught investors’ attention as director Frank Slootman divested 348,020 shares over a two-day period on August 18-19, 2026. The sale generated proceeds totaling $97.4 million, with execution prices falling between $319.07 and $333.37 per share.
The cloud data platform provider’s shares are currently changing hands near $321, not far from the 52-week peak of $341.95. Over the trailing twelve months, SNOW has delivered impressive returns of 65%.
These share dispositions occurred through a Rule 10b5-1 trading arrangement established by Slootman on September 19, 2025. Such pre-established plans allow corporate insiders to execute stock transactions according to predetermined schedules, helping them avoid potential insider trading complications.
The sales involved stock option exercises as part of the process. Slootman converted options into 300,000 shares at an exercise price of $8.88 apiece, representing a total expenditure of $2.66 million, before disposing of them at significantly elevated market valuations.
During the first day of transactions on August 18, he acquired 251,010 shares via option conversion and disposed of 299,030 shares. The following day saw him acquire and sell an additional 48,990 shares.
Following these transactions, Slootman’s direct ownership stands at merely 28,535 shares. This represents an 89.79% reduction in his personally held position. He maintains additional indirect holdings through various family trust structures.
Ongoing Divestment Strategy
This recent activity represents a continuation of Slootman’s methodical selling approach. Throughout May, he disposed of more than 837,000 shares in two separate transactions. Late May saw another 400,000 shares sold, with additional hundreds of thousands following during June and July.
Each of these sales occurred under the identical pre-scheduled trading arrangement.
The latest round of sales achieved considerably higher valuations compared to earlier transactions this year. His June dispositions fetched prices in the $224 to $264 range per share. The August sales commanded prices of $319 to $333, illustrating the stock’s substantial appreciation.
Wall Street Maintains Optimism
Notwithstanding substantial insider divestment activity, analyst sentiment toward SNOW remains predominantly positive. Among 40 analysts monitored by MarketBeat, 34 maintain Buy recommendations, five suggest Hold, and only one advises Sell. The average price objective stands at $320.65.
UBS recently elevated its price objective to $425, citing robust artificial intelligence demand and projecting 36-37% revenue expansion for the upcoming second quarter. TD Cowen increased its target to $370 while maintaining a Buy stance. Needham adjusted its target upward to $330, and Piper Sandler moved to $320.
The company’s most recent quarterly results were released on May 27. Revenue reached $1.39 billion, representing 33.5% year-over-year growth and surpassing analyst projections of $1.32 billion. Earnings per share of $0.39 exceeded the consensus estimate of $0.32.
Institutional ownership has expanded as well. Vanguard expanded its position by 5.1% during the fourth quarter. Jennison Associates grew its holdings by 27.7%. Norges Bank initiated a fresh position valued at approximately $974 million.
Market participants are anticipating Snowflake’s upcoming earnings announcement with considerable interest, particularly as UBS projects 36-37% product revenue growth for the reporting period.





